ALPA LABORATORIES
Back to Balance Sheet
|
ALPA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.49 Cr | ₹2.40 Cr | ₹3.06 Cr | ₹4.70 Cr | ₹0.23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALPA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹2.40 Cr |
| Mar2023 | ₹3.06 Cr |
| Mar2022 | ₹4.70 Cr |
| Mar2021 | ₹0.23 Cr |
How is Total Non-Current Liabilities of ALPA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 87.52 | |
| Mar2024 | ₹2.40 Cr | -21.70 | |
| Mar2023 | ₹3.06 Cr | -34.82 | |
| Mar2022 | ₹4.70 Cr | 1,986.67 | |
| Mar2021 | ₹0.23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹143.4 Cr | 1.2% | 0.7% | -34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | 1.2% |
0.7% |
-34.9% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses